Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

miR-511-3p modulates genetic programs of tumor-associated macrophages.

Squadrito ML, Pucci F, Magri L, Moi D, Gilfillan GD, Ranghetti A, Casazza A, Mazzone M, Lyle R, Naldini L, De Palma M.

Cell Rep. 2012 Feb 23;1(2):141-54. doi: 10.1016/j.celrep.2011.12.005. Epub 2012 Feb 9.

2.

Functions of miR-146a and miR-222 in Tumor-associated Macrophages in Breast Cancer.

Li Y, Zhao L, Shi B, Ma S, Xu Z, Ge Y, Liu Y, Zheng D, Shi J.

Sci Rep. 2015 Dec 22;5:18648. doi: 10.1038/srep18648.

3.

Mannose receptor modulates macrophage polarization and allergic inflammation through miR-511-3p.

Zhou Y, Do DC, Ishmael FT, Squadrito ML, Tang HM, Tang HL, Hsu MH, Qiu L, Li C, Zhang Y, Becker KG, Wan M, Huang SK, Gao P.

J Allergy Clin Immunol. 2017 Jun 17. pii: S0091-6749(17)30990-9. doi: 10.1016/j.jaci.2017.04.049. [Epub ahead of print]

PMID:
28629744
4.

MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.

Yang J, Zhang Z, Chen C, Liu Y, Si Q, Chuang TH, Li N, Gomez-Cabrero A, Reisfeld RA, Xiang R, Luo Y.

Oncogene. 2014 Jun 5;33(23):3014-23. doi: 10.1038/onc.2013.258. Epub 2013 Jul 8.

PMID:
23831570
5.

CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.

Dong P, Ma L, Liu L, Zhao G, Zhang S, Dong L, Xue R, Chen S.

Int J Mol Sci. 2016 Mar 1;17(3):320. doi: 10.3390/ijms17030320.

6.

Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.

Xu S, Wei J, Wang F, Kong LY, Ling XY, Nduom E, Gabrusiewicz K, Doucette T, Yang Y, Yaghi NK, Fajt V, Levine JM, Qiao W, Li XG, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB.

J Natl Cancer Inst. 2014 Jun 28;106(8). pii: dju162. doi: 10.1093/jnci/dju162. Print 2014 Aug.

7.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
8.

A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice.

Zonari E, Pucci F, Saini M, Mazzieri R, Politi LS, Gentner B, Naldini L.

Blood. 2013 Jul 11;122(2):243-52. doi: 10.1182/blood-2012-08-449306. Epub 2013 Mar 13.

9.

miR-142-3p inhibits cancer cell proliferation by targeting CDC25C.

Cao XC, Yu Y, Hou LK, Sun XH, Ge J, Zhang B, Wang X.

Cell Prolif. 2016 Feb;49(1):58-68. doi: 10.1111/cpr.12235. Epub 2016 Jan 25.

PMID:
26805039
10.

A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages.

Lagrange B, Martin RZ, Droin N, Aucagne R, Paggetti J, Largeot A, Itzykson R, Solary E, Delva L, Bastie JN.

Biochim Biophys Acta. 2013 Aug;1833(8):1936-46. doi: 10.1016/j.bbamcr.2013.04.007. Epub 2013 Apr 17.

11.

Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine.

Liu M, Xu A, Yuan X, Zhang Q, Fang T, Wang W, Li C.

J Transl Med. 2015 Jun 18;13:195. doi: 10.1186/s12967-015-0533-x.

12.

miR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammation.

Heinsbroek SE, Squadrito ML, Schilderink R, Hilbers FW, Verseijden C, Hofmann M, Helmke A, Boon L, Wildenberg ME, Roelofs JJ, Ponsioen CY, Peters CP, Te Velde AA, Gordon S, De Palma M, de Jonge WJ.

Mucosal Immunol. 2016 Jul;9(4):960-73. doi: 10.1038/mi.2015.113. Epub 2015 Nov 4.

PMID:
26530135
13.

Expression profiles of miRNAs in polarized macrophages.

Zhang Y, Zhang M, Zhong M, Suo Q, Lv K.

Int J Mol Med. 2013 Apr;31(4):797-802. doi: 10.3892/ijmm.2013.1260. Epub 2013 Jan 30.

PMID:
23443577
14.

In vivo depletion of CD206+ M2 macrophages exaggerates lung injury in endotoxemic mice.

Kambara K, Ohashi W, Tomita K, Takashina M, Fujisaka S, Hayashi R, Mori H, Tobe K, Hattori Y.

Am J Pathol. 2015 Jan;185(1):162-71. doi: 10.1016/j.ajpath.2014.09.005. Epub 2014 Oct 27.

PMID:
25447055
15.

Genetic variation of miRNA sequence in pancreatic cancer.

Zhu Z, Gao W, Qian Z, Miao Y.

Acta Biochim Biophys Sin (Shanghai). 2009 May;41(5):407-13.

16.

MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration.

Duan Z, Choy E, Harmon D, Liu X, Susa M, Mankin H, Hornicek F.

Mol Cancer Ther. 2011 Aug;10(8):1337-45. doi: 10.1158/1535-7163.MCT-11-0096. Epub 2011 Jun 10.

17.

Cell survival following radiation exposure requires miR-525-3p mediated suppression of ARRB1 and TXN1.

Kraemer A, Barjaktarovic Z, Sarioglu H, Winkler K, Eckardt-Schupp F, Tapio S, Atkinson MJ, Moertl S.

PLoS One. 2013 Oct 16;8(10):e77484. doi: 10.1371/journal.pone.0077484. eCollection 2013.

18.

MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.

Du C, Lv Z, Cao L, Ding C, Gyabaah OA, Xie H, Zhou L, Wu J, Zheng S.

J Transl Med. 2014 Sep 22;12:259. doi: 10.1186/s12967-014-0259-1.

19.

MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met.

Xu X, Chen H, Lin Y, Hu Z, Mao Y, Wu J, Xu X, Zhu Y, Li S, Zheng X, Xie L.

Mol Cells. 2013 Jul;36(1):62-8. doi: 10.1007/s10059-013-0044-7. Epub 2013 May 30.

20.

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.

Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E.

BMC Cancer. 2010 Jun 22;10:318. doi: 10.1186/1471-2407-10-318.

Supplemental Content

Support Center